Biosimilar Newsletter Archive

  1. 07.28.16 -- What Can Biosimilars Learn From The Diamond Industry?
    7/28/2016

    07/28/16 Biosimilar Development Newsletter

  2. 07.21.16 -- 5 Takeaways From The Amgen, Sandoz Biosimilar AdComs
    7/21/2016

    07/21/16 Biosimilar Development Newsletter

  3. 07.14.16 -- What Teva’s Play Reveals About Pharmaceutical Innovation
    7/14/2016

    07/14/16 Biosimilar Development Newsletter

  4. 07.13.16 -- Combination Product Insights Special Edition
    7/13/2016
    07/13/16
  5. 07.07.16 -- What To Know About Emerging Market Biosimilar Pathways
    7/7/2016

    07/07/16 Biosimilar Development Newsletter

  6. 06.30.16 -- How Biosimilar Manufacturers Are Approaching Biosimilar Education
    6/30/2016

    06/30/16 Biosimilar Development Newsletter

  7. 06.29.16 -- Combination Product Insights Special Edition
    6/29/2016
    06/29/16
  8. 06.23.16 -- BsUFA II: What Biosimilar Makers Need From FDA
    6/23/2016

    06/23/16 Biosimilar Development Newsletter

  9. 06.16.16 -- Brexit: Biosimilar Makers Beware
    6/16/2016

    06/16/16 Biosimilar Development Newsletter

  10. 06.09.16 -- What FDA Biosimilar Naming Tweak Could Mean For Manufacturers
    6/9/2016

    06/09/16 Biosimilar Development Newsletter